Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review (Q38644618)

5 September 2017

Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

5 September 2017

0 references

1 reference

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Anja Geerts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

M Bekaert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

B Lapauw

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

P Calders

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

24 November 2015

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

68-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26597657%20AND%20SRC:MED&resulttype=core&format=json

Histopathology of nonalcoholic fatty liver disease

7 June 2020

cites work

1 reference

Epidemiology and natural history of non-alcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

21 January 2018

1 reference

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages.

21 January 2018

1 reference

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice

21 January 2018

1 reference

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy

21 January 2018

1 reference

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

21 January 2018

1 reference

Adipokines in liver diseases

21 January 2018

1 reference

Leptin in nonalcoholic fatty liver disease: a narrative review

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

Serum chemerin and vaspin in non-alcoholic fatty liver disease

21 January 2018

1 reference

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

21 January 2018

1 reference

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

21 January 2018

1 reference

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery

21 January 2018

1 reference

Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?

21 January 2018

1 reference

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

21 January 2018

1 reference

Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort

21 January 2018

1 reference

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.

21 January 2018

1 reference

Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease

21 January 2018

1 reference

Plasma apelin levels in subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes

21 January 2018

1 reference

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.

21 January 2018

1 reference

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome.

21 January 2018

1 reference

Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood.

21 January 2018

1 reference

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver

21 January 2018

1 reference

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

21 January 2018

1 reference

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

Increased resistin gene and protein expression in human abdominal adipose tissue.

21 January 2018

1 reference

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells

21 January 2018

1 reference

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

Abnormal glucose homeostasis due to chronic hyperresistinemia

21 January 2018

1 reference

Role of resistin in diet-induced hepatic insulin resistance

21 January 2018

1 reference

Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

21 January 2018

1 reference

Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice

21 January 2018

1 reference

Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.

21 January 2018

1 reference

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects.

21 January 2018

1 reference

Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

21 January 2018

1 reference

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

21 January 2018

1 reference

Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.

21 January 2018

1 reference

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1.

21 January 2018

1 reference

Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue

21 January 2018

1 reference

Anti-inflammatory cytokines and risk of type 2 diabetes.

21 January 2018

1 reference

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose

21 January 2018

1 reference

Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation

21 January 2018

1 reference

Gene expression in human NAFLD.

21 January 2018

1 reference

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

21 January 2018

1 reference

Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

21 January 2018

1 reference

Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.

21 January 2018

1 reference

Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers

21 January 2018

1 reference

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

CCR2 promotes hepatic fibrosis in mice

21 January 2018

1 reference

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines

21 January 2018

1 reference